Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting.
about
The Three Bacterial Lines of Defense against Antimicrobial AgentsTargeting of PBP1 by β-lactams determines recA/SOS response activation in heterogeneous MRSA clinical strainsBiofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.Antibiotics trigger initiation of SCCmec transfer by inducing SOS responses.Lateral Antimicrobial Resistance Genetic Transfer is active in the open environmentIntegrons: past, present, and future.Structural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem-ciprofloxacin combination.Genomic interplay in bacterial communities: implications for growth promoting practices in animal husbandry.RpoS plays a central role in the SOS induction by sub-lethal aminoglycoside concentrations in Vibrio cholerae.Antimicrobial use in aquaculture re-examined: its relevance to antimicrobial resistance and to animal and human health.Genome sequence of Xanthomonas fuscans subsp. fuscans strain 4834-R reveals that flagellar motility is not a general feature of xanthomonads.Subinhibitory concentration of kanamycin induces the Pseudomonas aeruginosa type VI secretion system.Diversity of Class 1 Integron Gene Cassette Rearrangements Selected under Antibiotic Pressure.The SOS Response Master Regulator LexA Is Associated with Sporulation, Motility and Biofilm Formation in Clostridium difficile.Polycistronic transcription of fused cassettes and identification of translation initiation signals in an unusual gene cassette array from Pseudomonas aeruginosa.Antibiotic resistance shaping multi-level population biology of bacteria.Multiple Pathways of Genome Plasticity Leading to Development of Antibiotic Resistance.DNA damage responses in prokaryotes: regulating gene expression, modulating growth patterns, and manipulating replication forks.Structural insight into LexA-RecA* interaction.Differences in Integron Cassette Excision Dynamics Shape a Trade-Off between Evolvability and Genetic Capacitance.Pharmacokinetics, pharmacodynamics and therapeutics of pradofloxacin in the dog and cat.DNA damage repair and bacterial pathogensMicrobiological effects of sublethal levels of antibiotics.SOS, the formidable strategy of bacteria against aggressions.Integrons in the intestinal microbiota as reservoirs for transmission of antibiotic resistance genesEfflux pump induction by quaternary ammonium compounds and fluoroquinolone resistance in bacteria.Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins.Effects of 100 years wastewater irrigation on resistance genes, class 1 integrons and IncP-1 plasmids in Mexican soil.Concentration-dependent activity of antibiotics in natural environments.Genomic characterization of a local epidemic Pseudomonas aeruginosa reveals specific features of the widespread clone ST395.Environmental factors influencing the development and spread of antibiotic resistance.Complete nucleotide sequences of two KPC-2-encoding plasmids from the same Citrobacter freundii isolate.Impact of wastewater treatment on the prevalence of integrons and genetic diversity of integron gene cassettes.
P2860
Q26786956-12676B11-9125-4B59-BEAE-960FD5104914Q28486717-782A6A34-F306-4332-B0F6-67DBCFA58430Q30403958-8D01097F-CD03-4F8E-98CC-1966F3122270Q33580265-604FAF0C-A183-4384-8DD3-035A93BA5B25Q33674296-0126CD73-7E25-4F58-8F8A-A2B0F0D967DFQ33743517-5C1966D8-251D-426A-B1F6-6ED443AED5E7Q33798601-4D2AE645-73CE-4D7E-89CF-D56423A8D988Q34031581-93FC502C-BA82-402B-AC73-ABC47B641612Q34683559-317FD518-65C6-4770-B14E-08836ABD12EBQ34742045-54E66083-B6F8-4547-858E-B69DC7753A1DQ35032941-89FAB224-E06D-413D-8FE0-D3A352F5EF3CQ35049468-BA92A84D-FCC2-4876-90D0-62F9DB788970Q35682371-927BFE4A-A39F-4DA5-9C57-1B7821CB3961Q35872877-E1AB5B61-BBD5-47CD-977F-06194E839AF2Q36347805-7FF10730-D521-497F-AE57-5F2CCAC3C6D1Q36660833-7269E03B-C5C8-4352-B694-3959F240058AQ36683593-A3312905-D951-4AF1-8BF2-CC29A311A6FDQ37258696-CEC2E790-BFCB-45F7-91EB-1F1436B4EF95Q37327601-37D82D41-FD3B-47E5-B3E5-4C61AED236A4Q37727172-E5ACE4D1-CF5E-4D8E-83B2-0239DE66F58FQ38081184-3033BA23-8AE9-4EC8-B506-09ECEA85CF9EQ38163529-8FF11166-90E9-4164-A532-C7821BF2EB15Q38214805-CC749165-8948-429D-839A-AE1BBCD05782Q38219786-1690A66D-8DD9-428B-AC5F-02E77D3D6E0CQ38273295-2CAF8C34-050C-4546-B8EB-6010D8460809Q38671076-CDDC3502-2EFB-4616-9FDD-0D7D5139730BQ40696824-B118E8D4-9828-449F-BAAA-595759506AB1Q41416806-3A77EFDD-5AAD-4B02-A441-3FAB7DE3587EQ43245583-0B6B0CD5-A85B-433D-86C6-E656F7F43B80Q44842487-1FA846C8-F298-455C-95C7-B5B7E27693D4Q47631000-FF0B4879-9861-4FAE-BEDC-E6543131BF5DQ47726417-84AB1A93-AB7A-477B-AD7F-A0D01BB80EE9Q51151449-EE342357-AB8D-4410-9954-3DA01928EBB9
P2860
Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Evidence for induction of inte ...... esponse in a clinical setting.
@ast
Evidence for induction of inte ...... esponse in a clinical setting.
@en
Evidence for induction of inte ...... esponse in a clinical setting.
@nl
type
label
Evidence for induction of inte ...... esponse in a clinical setting.
@ast
Evidence for induction of inte ...... esponse in a clinical setting.
@en
Evidence for induction of inte ...... esponse in a clinical setting.
@nl
prefLabel
Evidence for induction of inte ...... esponse in a clinical setting.
@ast
Evidence for induction of inte ...... esponse in a clinical setting.
@en
Evidence for induction of inte ...... esponse in a clinical setting.
@nl
P2093
P2860
P1433
P1476
Evidence for induction of inte ...... esponse in a clinical setting.
@en
P2093
Catherine Llanes
Didier Hocquet
Didier Mazel
Hemantha D Kulasekara
Michelle Thouverez
Patrick Plésiat
Samuel I Miller
Xavier Bertrand
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002778
P577
2012-06-14T00:00:00Z